Retour aux projets

17557.2 PFLS-LS

Target validation in acute T cell-mediated inflammatory diseases..

Résumé

Target validation in acute T cell-mediated inflammatory diseases..

Textes supplémentaires

Abstract

Our goal is to identify the key molecular target(s) responsible for the tissue damage observed in acute T cell-mediated inflammatory diseases (aTMID). Cytotoxic immune cells have been shown to play a pivotal role in the pathogenesis of aTMID. These cells exert their cytotoxic activities via effector proteins. Amongst them granulysin has been shown to play a central role. We aim at identifying potential synergies between granulysin and other putative effector proteins.

Participants

Dean Yann

Wirtschaftspartner

yann.dean@dermabiotech.ch

DermAbiotech Sàrl Dean Yann chemin des Aulx 14 1228 Plan-les-Ouates GE CH

Lars French

Kontaktperson

lars.french@usz.ch

USZ Universitätsspital Zürich Dermatologie Lars French Gloriastrasse 31 8091 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2015-09-30
Date de fin
2017-11-30
Coûts totaux approuvés
CHF 231180.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%